Hair Loss in Women

Seminars in Cutaneous Medicine and Surgery

Volumn 28, Issue 1, 2009, Pages 19-32

  Camacho Martínez, Francisco M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL NICOTINATE; ANTIANDROGEN; BROMOCRIPTINE; CABERGOLINE; CANRENONE; CIMETIDINE; CORTICOSTEROID; CYCLOSPORIN; CYPROTERONE ACETATE; DEFLAZACORT; DEXAMETHASONE; DIAZOXIDE; DROSPIRENONE; DUTASTERIDE; ETHINYLESTRADIOL; FINASTERIDE; FLUTAMIDE; IRON; LEUPRORELIN; METFORMIN; MINOXIDIL; PHYTOESTROGEN; PLACEBO; PREDNISONE; PROGESTERONE; RETINOIC ACID; SPIRONOLACTONE; UNINDEXED DRUG; VIPROSTOL; VITAMIN;

ABSENCE OF SIDE EFFECTS; ADRENAL SUPPRESSION; ADRENAL TUMOR; ALOPECIA; ANAMNESIS; ANDROGEN RELEASE; ANTIANDROGEN THERAPY; BREAST HYPERTROPHY; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTACT DERMATITIS; CUSHINGOID SYNDROME; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRY SKIN; ECTOPIC HORMONE PRODUCTION; EJACULATION DISORDER; ENDOCRINE DISEASE; EPILUMINESCENCE MICROSCOPY; ERYTHEMA ANNULARE CENTRIFUGUM; ERYTHEMA MULTIFORME; EVENING DOSAGE; FATIGUE; FEMALE ANDROGENETIC ALOPECIA; FEMALE ANDROGENETIC ALOPECIA WITH MALE PATTERN; FEMALE TYPE ALOPECIA; FEMINIZATION; FETOTOXICITY; FLUID RETENTION; GYNECOMASTIA; HEADACHE; HIRSUTISM; HORMONAL THERAPY; HUMAN; HYPERANDROGENISM; HYPERKALEMIA; HYPERPROLACTINEMIA; HYPERTENSION; HYPERTRICHOSIS; HYSTERECTOMY; IMPOTENCE; INCIDENCE; INSULIN RESISTANCE; IRON DEFICIENCY; IRRITANT DERMATITIS; LABORATORY TEST; LETHARGY; LIBIDO DISORDER; LICHENOID ERUPTION; LIFESTYLE MODIFICATION; LIVER TOXICITY; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS; MACULOPAPULAR RASH; MASTALGIA; MENOPAUSAL SYNDROME; MENORRHAGIA; MENTAL INSTABILITY; MORNING DOSAGE; ONSET AGE; OVARY POLYCYSTIC DISEASE; OVARY TUMOR; PATHOPHYSIOLOGY; PERSISTENT ADRENARCHE SYNDROME; PIGMENT DISORDER; POSTOPERATIVE COMPLICATION; PREVALENCE; PRURITUS; RAYNAUD PHENOMENON; REVIEW; SIDE EFFECT; SKIN MANIFESTATION; SKIN SCALING; STOMACH DISCOMFORT; URTICARIA; VASCULITIS; WEIGHT GAIN; WEIGHT REDUCTION; XEROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALOPECIA; CHILD; DERMATOLOGIC AGENTS; FEMALE; HUMANS; HYPERANDROGENISM; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 63049135048     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2009.01.001     Document Type: Review

References (111)

1. Olsen E.A. Female pattern hair loss. J Am Acad Dermatol 45 (2001) S70-S80
2. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97 (1977) 247-254
3. Olsen E.A. The midline part: An important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol 40 (1999) 106-109
4. Camacho F., and Sanchez-Pedreño P. Alopecia androgenética. Monogr Dermatol 2 (1989) 107-117
5. Camacho F. Acné en el síndrome SAHA. In: Piquero Martin J. (Ed). Acné: Manejo racional (1995), Mediciencia Editora CA, Caracas, Venezuela 19-34
6. Aizawa H., and Niimura M. Adrenal androgen abnormalities in women with late onset and persistent acné. Arch Dermatol Res 284 (1993) 451-455
7. Price V.H. No Advances en tricoloqia. In: Camacho F. (Ed). III curso internacional de avances en dermatología (1994), Aula Médica, Madrid, Spain 41-80
8. Biondo S., Goble D., and Sinclair R. Women who present with female pattern hair loss tend to underestimate the severity of their hair loss. Br J Dermatol 150 (2004) 750-752
9. Camacho F., and Rodriguez-Rey E. Alopecias de patrón femenino en adolescencia y mujer premenopáusica. Monogr Dermatol 20 (2007) 261-292
10. Tosti A., Iorizzo M., and Piraccini B.M. Androgenetic alopecia in children: Report of 20 cases. Br J Dermatol 152 (2005) 556-559
11. Hamilton J.B. Patterned loss hair in man. Types and incidence. Ann NY Acad Sci 53 (1951) 708-728
12. Birch M.P., Lalla S.C., and Messenger A.G. Female pattern hair loss. Clin Exp Dermatol 27 (2002) 383-388
13. Nissimov J., and Elchalal U. Scalp hair diameter increases during pregnancy. Clin Exp Dermatol 28 (2003) 525-530
14. Rushton D.H., and Ramsay I.D. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women. Clin Endocrinol (Oxf) 36 (1992) 421-427
15. Kantor J., Kessler L.J., Brooks D.G., and Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 121 (2003) 985-988
16. Camacho F., and García-Hernández M.J. Psychological features of androgenetic alopecia. J Eur Acad Dermatol Venereol 16 (2002) 467-480
17. Dolte K.S., Girman C.J., Hartmaler S., et al. Development of a health-related quality of life questionnaire for women with androgenetic alopecia. Clin Exp Dermatol 25 (2000) 637-642
18. Guerra A., and Cornejo-Navarro P. Déficit de biotinidasa. Piel 13 (1998) 242-247
19. Cornejo-Navarro P., Guerra A., Alvarez G., et al. Cutaneous and neurologic manifestations of biotinidase deficiency. Int J Dermatol 39 (2000) 363-382
20. Hediger C., Rost B., and Itin P. Cutaneous manifestations in anorexia nervosa. Schweitz Med Wochenschr 130 (2000) 565-575
21. Randall V.A. Androgens. The main regulator of human hair growth. In: Camacho F., Randall V.A., and Price V.H. (Eds). Hair and Its Disorders. Biology, Pathology and Management (2000), Martin Dunitz Ed, London, England 70-82
22. Norwood O.T. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 27 (2001) 53-54
23. Norwood O.T., and Lehr B. Female androgenetic alopecia: A separate entity. Dermatol Surg 26 (2000) 679-682
24. Carey A.H., Chan K.L., Short F., et al. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol 38 (1993) 653-658
25. Hoffmann R. Male androgentic alopecia. Clin Exp Dermatol 27 (2002) 373-382
26. Hillmer A.M., Flaquer A., Hanneken S., et al. Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. Am J Hum Genet 82 (2008) 737-743
27. Randall V.A. Androgens and hair growth. Dermatol Ther 21 (2008) 314-328
28. Camacho F. La pérdida del cabello en la mujer. In: Grimalt R. (Ed). Cuidemos de nuestro pelo (2007), Farmalia Com, Barcelona, Spain 61-103
29. Ludwig E., Montagna W., and Camacho F. Female androgenetic alopecia. In: Camacho F., and Montagna W. (Eds). Tricology: Diseases of the Pilosebaceous Follicle (1997), Aula Médica Group, Madrid, Spain 343-355
30. Camacho F. Clínica de las alopecias. Clasificación general. Monogr Dermatol 1 (1988) 33-72
31. Camacho F., and Ludwig E. Female pattern hair loss. Female androgenetic alopecia. Clinico-pathological features. Monogr Dermatol 18 (2005) 54-74
32. Olsen E.A., Messenger A.G., Shapiro J., et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 52 (2005) 301-311
33. Olsen E.A. Female pattern hair loss. In: Blume-Peytavi U., Tosti A., Whiting D.A., and Trüeb R. (Eds). Hair Growth and Disorders (2008), Springer-Verlag, Berlin, Germany 171-187
34. Rebora A., Guarrera M., Baldari M., et al. Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: A simple noninvasive method. Arch Derm 141 (2005) 1243-1245
35. Van Neste D., de Brouwer B., and De Coster W. The phototrichogram: Analysis of some factors of variation. Skin Pharmacol 7 (1994) 67-72
36. Bouhanna P. Le tractiophototrichogramme, méthode d'appréciation objective d'une chute de cheveus. Ann Dermatol Vénéréol 115 (1988) 759-764
37. Camacho F. Diagnosis in trichology. In: Camacho F., and Montagna W. (Eds). Tricology: Diseases of the Pilosebaceous Follicle (1997), Aula Médica Group, Madrid, Spain 97-112
38. Tosti A. Dermoscopy of hair and scalp disorders with clinical and pathological correlations (2007), Informe Healthcare, Bologna, Italy
39. Braun-Falco O., and Heilgemeir G.P. The trichogram. Structural and functional basis, performance and interpretation. Semin Dermatol 4 (1985) 40-51
40. Serrano Ortega S., Dulanto Campos M.C., Simon F., et al. Diámetro del tallo piloso en la alopecia androgenética femenina. Actas Dermosifiliogr 85 (1994) 474-476
41. Rushton D.H. Management of hair loss in women. Dermatol Clin 11 (1993) 47-53
42. Hoffmann R. TrichoScan: A novel tool for the analysis of hair growth in vivo. J Invest Dermatol Symp Proc 8 (2003) 109-115
43. Uno H., and Kurata S. Folliculogram: Autoradiography. In: Camacho F., and Montagna W. (Eds). Tricology: Diseases of the Pilosebaceous Follicle (1997), Aula Médica Group, Madrid, Spain 119-127
44. Whiting D.A. Chronic telogen effluvium: Increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 35 (1996) 899-906
45. Melegos D.N., Yu H., Ashok M., et al. Prostate-specific antigen in female serum, potential new marker of androgen excess. J Clin Endocrinol Metab 82 (1997) 777-780
46. Escobar-Morreale H.F., Serrano-Gotarredona J., Avila S., et al. The increased circulating prostate specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J Clin Endocrinol Metab 83 (1998) 2580-2584
47. Negri C., Tosti F., Dorizzi R., et al. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: Evidence that serum PSA is a marker of androgen action in women. J Clin Endocrinol Metab 85 (2000) 81-84
48. Camacho F., López Elorza F., Rodríguez Rey E., et al. Prostate-specific antigen levels as hyperandrogenism marker in women. J Eur Acad Dermatol Venereol 23 (2009) 221-223
49. Lowenstein E.J. Diagnosis and management of the dermatologic manifestation of the polycystic ovary syndrome. Dermatol Ther 19 (2006) 210-223
50. Camacho F. Hirsutism. In: Blume-Peytavi U., Tosti A., Whiting D.A., and Trüeb R. (Eds). Hair Growth and Disorders (2008), Springer-Verlag, Berlin, Germany 357-377
51. Camacho F. Medical treatment of androgenetic alopecia. In: Camacho F., and Montagna W. (Eds). Tricology: Diseases of the Pilosebaceous Follicle (1997), Aula Médica Group, Madrid, Spain 357-386
52. Camacho F., and Tosti A. Tratamiento médico de las alopecias femeninas. Monogr Dermatol 18 (2005) 92-117
53. Jacobs J.P., Szpunar C.A., and Warner M.L. Use of topical minoxidil for androgenetic alopecia in women. Int J Dermatol 32 (1993) 758-762
54. DeVillez R.L., Jacobs J.P., Szpunar C.A., et al. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol 130 (1994) 303-307
55. Tosti A., Camacho-Martínez F., and Dawber R. Management of androgenetic alopecia. J Eur Acad Dermatol Venereol 12 (1999) 205-214
56. Bazzano G.S., Terezakis N., and Galen W. Topical minoxidil for hair growth promotion. J Am Acad Dermatol 15 (1986) 880-883
57. Savin R.C., and Atton A.V. Minoxidil. Update on its clinical role. Dermatol Clin 16 (1993) 188-192
58. Camacho F., and Mazuecos J. Avances en terapéutica dermatológica 1993. Monogr Dermatol 7 (1994) 211-235
59. Yano K., Brown L.F., and Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 107 (2001) 409-417
60. Camacho F., and Sanchez-Pedreño P. Sindrome SAHA. Piel 6 (1991) 272-286
61. Georgala S., Katuolis A.C., Georgala C., et al. Topical estrogen therapy for androgenetic alopecia in menopausal females. Dermatology 208 (2004) 178-179
62. Sinclair R.D., and Dawber R.P.R. Androgenetic alopecia in men and women. Clin Dermatol 19 (2001) 167-178
63. Camacho F. Drug treatment of hirsutism. In: Camacho F., Randall V.A., and Price V.H. (Eds). Hair and its Disorders. Biology, Pathology and Management (2000), Martin Dunitz Ed, London, UK 369-381
64. Camacho F. Hypertrichosis and hirsutism. In: Bolognia J., Jorizzo J.L., and Rapini R.P. (Eds). Dermatology. (ed 2) (2008), Mosby Ed, London, UK 1007-1018
65. Camacho F. Tratamiento del hirsutismo. Actas Dermosifiliogr 97 (2006) 33-44 (suppl 1)
66. Neumann F., Schleusener A., and Albring M. Pharmacology of antiandrogens, in Hammerstein. Androgenization in Women, Acne, Seborrhoea, Androgenetic Alopecia and Hirsutism: lectures and discussions of a symposium, Berlin, 23rd-24th February 1979 (1980), Excerpta Medica, Bridgewater, NJ 147-192
67. Camacho F., and Sánchez-Pedreño P. Espironolactonaen/en el tratamiento del síndrome SAHA. Med Cut Iber Latin Am 21 (1993) 107-114
68. Gupta A.K., Knowles S.R., and Shear N.H. Spironolactone associated cutaneous effects: A case report and a review of the literature. Dermatology 189 (1994) 402-405
69. Schon M.P., Tebbe B., Trautmann C., et al. Lichenoid drug eruption induced by spironolactone. Acta Dermatol Venereol (Stockh) 74 (1994) 476
70. Martín-Hernández T., Jorquera E., Torres A., et al. Eficacia de la flutamida y el acetato de ciproterona en el tratamiento del hirsutismo asociado al síndrome de los ovarios poliquísticos. Actas Dermosifiliogr 86 (1995) 327-334
71. Dodin S., Faure N., and Cédrin I. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin Endocrinol 43 (1995) 575-582
72. Muderris I.I., Bayran B.F., and Guven M. Treatment of hirsutism with lowest-dose flutamide, (62.5 mg/d). Gynecol Endocrinol 14 (2000) 38-41
73. Aram H. Treatment of female androgenetic alopecia with cimetidine. Gastroenterology 76 (1979) 504-508
74. Leyden J., Bergfeld W., Drake L., et al. A systemic type I 5α-reductase inhibitor is ineffective in the treatment of acne vulgaris. J Am Acad Dermatol 50 (2004) 443-447
75. Flores E., Bratoeff E., Cabeza M., et al. Steroid 5α-reductase inhibitors. Mini Rev Med Chem 3 (2003) 225-237
76. Bratoeff E., Cabeza M., Ramirez E., et al. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogen and 5α-reductase inhibitors. Curr Med Chem 12 (2005) 927-943
77. Rogers N.E., and Avram M.R. Medical treatment for male and female pattern hair loss. J Am Acad Dermatol 59 (2008) 547-566
78. Dallob A., Sadik N.S., Unger W., et al. The effect of finasteride, a 5-alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentration in patients with male pattern baldness. J Clin Endocrinol Metab 79 (1994) 703-706
79. Drake L., Hordinsky M., Fiedler V., et al. The effect of finasteride, a 5-alpha-reductase inhibitor, on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 41 (1999) 550-554
80. Kaufman K.D., Olsen E.A., Whiting D., et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 39 (1998) 578-589
81. Leyden J., Dunlap F., Miller B., et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 40 (1999) 930-937
82. Camacho F., and Hirsutismo. Enfoque clínico-terapéutico II. Act Terap Dermatol (Arg) 24 (2001) 190-206
83. Price V.H., Roberts J.L., Hordinsky M., et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 43 (2000) 768-776
84. Shum K.W., Cullen D.R., and Messenger A.G. Hair loss in women with hyperandrogenism: Four cases responding to finasteride. J Am Acad Dermatol 47 (2002) 733-739
85. Thai K.-E., and Sinclair R.D. Finasteride for female androgenética alopecia. Br J Dermatol 147 (2002) 812-813
86. Trüeb R.M. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women. Dermatology 209 (2004) 202-207
87. Valsecchi R., Leghissa P., and Riva M. Female androgenetic alopecia treated by finasteride: A case forward. Acta Derm Venereol 84 (2004) 488-489
88. Iorizzo M., Vinzenci C., Voudouris S., et al. Finasteride treatment of female pattern hair loss. Arch Dermatol 142 (2006) 298-302
89. Moreno-Ramírez D., and Camacho-Martínez F. Frontal fibrosing alopecia: A survey in 16 patients. J Eur Acad Dermatol Venereol 19 (2005) 700-705
90. Tosti A., Piraccini B.M., Iorizzo M., and Misciali C. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol 52 (2005) 55-60
91. Iorizzo M., and Tosti A. Trastornos del cabello en mujeres postmenopausicas. Monogr Dermatol 20 (2007) 189-203
92. Kohler C., Tschumi K., Bodmer C., et al. Effect of finasteride, 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone. Gynecol Endocrinol 23 (2007) 142-145
93. Olsen E.A., Hordinsky M., Whiting D., et al. The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol 55 (2006) 1014-1023
94. Olszewska M., and Rudnicke L. Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol 4 (2005) 637-640
95. Debruyme F., Barkin J., van Erps P., et al. Efficacy and safety of long-term treatment with the dual 5α-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia. Eur Urol 46 (2004) 488-495
96. Fernández Olarte D., Morán García A., Iglesias Bonilla P., et al. Ginecomastia por dutasterida. Med Clin (Barc) 128 (2007) 250
97. Barbieri R.L., and Gargiulo A.R. Metformin for the treatment of the polycystic ovary syndrome. Minerva Ginecol 56 (2004) 63-79
98. Harborne L., Fleming R., Lyall H., et al. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 4116-4123
99. Kazerooni T., and Dehghan-Kooshkghazi M. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Gynecol Endocrinol 17 (2003) 51-56
100. Schwartz S., Fonseca V., Berner B., et al. Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes. Diab Care 29 (2006) 759-764
101. Falsetti L., De Fusco D., and Eleftheriou G. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome. Gynecol Endocrinol 11 (1997) 251-257
102. Colao A., Lombardi G., and Annunziato L. Cabergoline. Expert Opin Pharmacother 1 (2000) 555-574
103. Rushton D.H., and Ramsay I.D. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women. Clin Endocrinol (Oxf) 36 (1992) 421-427
104. Kantor J., Kessler L.J., Brooks D.G., and Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 121 (2003) 985-988
105. Prager N., Bickett K., French N., et al. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitor of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med 8 (2002) 142-152
106. Peeters P.H.M., Slimani N., van der Schouw Y.T., et al. Variations in plasma phytoestrogen concentrations in European adults. J Nutr 137 (2007) 1294-1300
107. Verheus M., van Gils C.H., Keinan-Boker L., et al. Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 25 (2007) 648-655
108. Muti P., Awad A.B., Schünemann H., et al. A plant food-based diet modifies the serum β-sitosterol concentration in hyperandrogenic postmenopausal women. J Nutr 133 (2003) 4252-4255
109. Iwasaki M., Inoue M., Otani T., et al. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: A nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol 26 (2008) 1677-1683
110. Pasquali R., Fabbri R., Venturoli S., et al. Effect of weight loss and anti-androgenic therapy on sex-hormone blood levels and insulin resistance in obese patients with polycystic ovary syndrome. Am J Obstet Gynecol 154 (1986) 139-144
111. Camacho F. Cleasing: Maintenance, decorative and therapeutic cosmetics: Shampoos. Conditioners. Dyes. Permanent waves. Hair setting lotions and sprays. Fixing agents and others. Adverse reactions. Legislation. In: Camacho F., and Montagna W. (Eds). Tricology: Diseases of the Pilosebaceous Follicle (1997), Aula Mediea Group, Madrid, Spain 641-661